Other Research Publications

How Does Prognosis of NETs Differ Based on Site of Origin? by Dave Levitan

An analysis of more than 70,000 patients revealed significant differences with regard to survival between different sites of origin for neuroendocrine tumors (NETs). These differences could help guide therapy in these malignancies.

Click here to read the full article

From Patent to Patient 

Analysing access to innovative cancer drugs. 

The Institute of Cancer Research (ICR) have produced a report which asks how we can best harness advances in science to bring innovative drugs to patients. It is designed to help reshape the landscape for drug discovery and development – and create tomorrow’s cancer treatments.

Click here to read the full report

Nothing But NET: A Review of Neuroendocrine Tumors and Carcinomas

This review covers the diverse topic of neuroendocrine neoplasms ( NENs).

Click here to read the full report

The Colorful Palette of Neuroendocrine Neoplasms in the Genitourinary Tract

A review of  the  rare NENs of the genitourinary tract. 

Click here to read the full report

Liver Transplantation in patients with liver metastases from neuroendocrine tumors – A Systematic Review

A controversial topic with no clear answers yet, but a very strict selection process is key.

Click here to read the full report

Editorial for Neuroendocrine Tumor for Liver Transplant

Still a rare indication for liver transplantation. The efficacy of this treatment for NETs is unproven.

Click here to read the full report